Axis Pension Fund crosses ₹20,000 crore in AUM, doubles assets in 15 months

 

Axis Pension Fund, the pension fund management arm of Axis Asset Management Company Limited (Axis AMC) and a step-down subsidiary of Axis Bank Limited, has crossed ₹20,000 crore in Assets Under Management (AUM), marking a significant milestone in its growth journey and reinforcing its position among the fastest-growing players in India’s non-government pension segment.

 

The milestone comes on the back of strong momentum in the business, with Axis Pension Fund adding its latest ₹10,000 crore in AUM in just 15 months (from June 2025 to Aug 2026). The accelerated growth reflects the increasing trust among subscribers and partners, expanding distribution reach and growing adoption of NPS as a long-term retirement planning solution.

 

The growth has been supported by a strong focus on building a broad-based NPS franchise through Axis Bank’s distribution network. The business has continued to expand its reach and strengthen engagement across retail, affluent, corporate, government and institutional segments, while strengthening execution across customer segments and product categories. This diversified approach has enabled Axis Pension Fund to build a sustainable presence across the pension ecosystem.

 

Commenting on the milestone, Mr. Sumit Shukla, Managing Director & CEO, Axis Pension Fund, said, “Crossing ₹20,000 crore in AUM is an important milestone for Axis Pension Fund and, more importantly, reflects the trust that our subscribers and partners continue to place in us. The increase in AUM demonstrates the momentum we are seeing in the business and the growing acceptance of NPS as a retirement solution. As we scale further, our focus will remain on making pension solutions simpler and more accessible, while maintaining the highest standards of compliance, prudent investment management and customer security.”

 

India’s pension industry is expanding in an accelerated manner, supported by increasing awareness around retirement planning, deeper customer penetration and greater accessibility of pension products. Axis Pension Fund is focused on leveraging this opportunity along with technology and customer-centric initiatives to expand NPS adoption.

 

One such initiative by Axis Pension Funds is the Tatkal onboarding journey, which enables customers to open an NPS account in approximately 15–20 seconds, significantly reducing the turnaround time and making the onboarding process faster and more seamless. The pension fund house is also leveraging initiatives such as MSF (Multiple Scheme Framework), NPS Swasthya and NPS Vatsalya to broaden pension coverage and cater to evolving customer needs across segments.

 

“As we look ahead, we see significant headroom for growth. Our priority is to combine technology-led customer experiences with strong governance and investment discipline. Ultimately, safeguarding customers’ retirement savings and building long-term trust will remain central to our growth,” Mr. Shukla added.

 

Axis Pension Fund is among the fastest-growing players in the non-government pension segment, with its accelerated AUM trajectory underscoring the growing momentum behind its business. The company remains focused on expanding access to NPS and helping more Indians build a financially secure retirement through disciplined, long-term investing.

Comments

Post a Comment

Popular posts from this blog

A graphic novel about Anglo-Indian heritage with stunning illustrations

Image
The launch event for The History of Anglo-Indians: A Graphic Novel, a profound exploration of heritage, identity, and untold stories, was held on Saturday, August 8, 2026, at the C.P. Arts Convention Centre on Eldams Road in Chennai. The evening featured Dr. Oscar C. Nigli, the Senior National Vice-President of the All-India Anglo-Indian Association, as the esteemed special guest. Dr. Nigli is also a former Dean and Professor at Loyola College in Chennai, as well as a Former Anglo-Indian Member of the Legislative Assembly in Tamil Nadu. Attendees were treated to an insightful presentation by Keith Butler, who shared the research and creative journey behind The History of Anglo-Indians, followed by a discussion with the author. The graphic novel is brought to life by the stunning illustrations of Harry MacLure, a talented writer, cartoonist, artist, and comic book illustrator based in Chennai. MacLure is well known for his role as the editor of Anglos In The Wind, the longest-running ...
Read more

BPCL Dealer network launches “Fuelling the Festive Spirit” Campaign

Image
  Bharat Petroleum Corporation Limited (BPCL) dealer network has rolled out its festive season campaign, “Fuelling the Festive Spirit”, from 22nd September to 31st October 2025 across 3,000 Retail Outlets in Andhra Pradesh, Telangana, Karnataka, and Tamil Nadu.   Customers fuelling up with eligible transactions can win exciting prizes of 17 car and  83 Bikes through QR-based digital  slogan context participation. BPCL spokesperson said, “Festivals in India are a time of joy, giving, and togetherness. With ‘Fuelling the Festive Spirit,’ we are delighted to reward our customers and empower our frontline teams, making every visit to our retail outlets during this festive season truly memorable.”
Read more

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program

Image
First Private Hospital in India to Successfully Complete CAR T Cell Therapy.  In a ground-breaking development, Apollo Cancer Centres (ACCs) has emerged as the first private hospital group in India to have a successfully complete CAR-T cell program and to further augment it, the group will now provide access to Made in India CAR-T cell therapy, beginning with NexCAR19 (Actalycabtagene autoleucel), for the treatment of B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 years and above.   Marking a historic moment in the country's medical landscape , Dr. T Raja, Director of Medical Oncology at ACC, Chennai, spearheaded the development of this revolutionary clinical program, and has successfully treated six patients till date.   CAR-T cell therapies, often known as living drugs involve the extraction of a patients T-cells (a type of white blood cells whose function is to fight cancer cells) through a process known as Apheresis. These T-cells are t...
Read more